EV/EBITDA
-15.44
+1.41+8.37%
Thu, 06 Mar 2025 21:41:37 GMT
Summary
- As of March 7, 2025, TARS EV/EBITDA is -15.44, with a rise of +1.41 (+8.37%) during the most recent trading day.
- Over the past year, TARS EV/EBITDA has dropped by -6.33 (-69.48%).
- TARS EV/EBITDA is now -586.22% below its all-time high of -2.25.
Performance
TARS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
TARS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +8.4% | -8.4% | -8.3% |
| 1 m1 month | +18.4% | -18.4% | -18.3% |
| 3 m3 months | -9.2% | -8.1% | -12.3% |
| 6 m6 months | -111.2% | +56.4% | +42.4% |
| ytdytd | +21.5% | -21.5% | -21.3% |
| 1 y1 year | -69.5% | +37.5% | +17.2% |
| 5 y5 years | - | - | - |
TARS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -2.8% | -18.93 | +18.4% | |
| 3 m | 3-month | -14.14 | -9.2% | -20.42 | +24.4% |
| 6 m | 6-month | -7.31 | -111.2% | -20.42 | +24.4% |
| 1 y | 1-year | -5.23 | -195.2% | -20.42 | +24.4% |
| 3 y | 3-year | -2.25 | -586.2% | -20.42 | +24.4% |
| 5 y | 5-year | -2.25 | -586.2% | -126.62 | +87.8% |
| alltime | all time | -2.25 | -586.2% | -126.62 | +87.8% |
Tarsus Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -15.44(-21.5%) |
| 2024 | -19.66(+420.1%) |
| 2023 | -3.78(-34.8%) |
| Date | Value |
|---|---|
| 2022 | -5.80(-75.5%) |
| 2021 | -23.65(-5.4%) |
| 2020 | -25.00 |
FAQ
- What is Tarsus Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Tarsus Pharmaceuticals?
- What is TARS EV/EBITDA year-to-date change?
- What is Tarsus Pharmaceuticals EV/EBITDA year-on-year change?
What is Tarsus Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of TARS is -15.44
What is the all time high EV/EBITDA for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high EV/EBITDA is -2.25
What is TARS EV/EBITDA year-to-date change?
Tarsus Pharmaceuticals EV/EBITDA has changed by +4.22 (+21.46%) since the beginning of the year
What is Tarsus Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, TARS EV/EBITDA has changed by -6.33 (-69.48%)